Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is 11.36% higher on its value in year-to-date trading and has touched a low of $100.52 and a high of $157.98 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The NBIX stock was last observed hovering at around $144.13 in the last trading session, with the day’s gains setting it 2.6%.
Currently trading at $146.73, the stock is 0.34% and 4.51% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.86 million and changing 1.80% at the moment leaves the stock 10.51% off its SMA200. NBIX registered 45.00% gain for a year compared to 6-month gain of 7.66%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -0.27% loss in the last 1 month and extending the period to 3 months gives it a 5.55%, and is -4.19% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.06% over the week and 2.85% over the month.
Neurocrine Biosciences, Inc. (NBIX) has around 1400 employees, a market worth around $14.82B and $2.12B in sales. Current P/E ratio is 44.33 and Fwd P/E is 21.73. Profit margin for the company is 16.00%. Distance from 52-week low is 45.97% and -7.12% from its 52-week high. The company has generated returns on investments over the last 12 months (12.27%).
The EPS is expected to grow by 88.37% this year
The shares outstanding are 100.98M, and float is at 98.74M with Short Float at 2.66%.
Neurocrine Biosciences, Inc. (NBIX) Insider Activity
The most recent transaction is an insider sale by Delaet Ingrid, the company’s Chief Regulatory Officer. SEC filings show that Delaet Ingrid sold 273 shares of the company’s common stock on Aug 06 ’24 at a price of $147.70 per share for a total of $40322.0. Following the sale, the insider now owns 6607.0 shares.
Neurocrine Biosciences, Inc. disclosed in a document filed with the SEC on Aug 01 ’24 that Cooke Julie (Chief Human Resources Officer) sold a total of 12,632 shares of the company’s common stock. The trade occurred on Aug 01 ’24 and was made at $153.26 per share for $1.94 million. Following the transaction, the insider now directly holds 18202.0 shares of the NBIX stock.
Still, SEC filings show that on Aug 01 ’24, Lippoldt Darin (Chief Legal Officer) disposed off 2,996 shares at an average price of $154.01 for $0.46 million. The insider now directly holds 39,740 shares of Neurocrine Biosciences, Inc. (NBIX).
